tirzepatide pdf 2025 Early Dose Escalation of after Switching from Semaglutide in Type 2 Diabetes Mellitus Bridging the gap between GLP1-receptor

Start at a low weekly dose and increase slowly

There are currently no FDA-approved generic versions of Mounjaro, Zepbound, or any other tirzepatide products

Under normal conditions, GLP-1 helps your body: release insulin when blood sugar rises reduce glucagon when appropriate slow how quickly food leaves the stomach send fullness signals to the brain reduce appetite after a meal GLP-1 medications imitate or amplify this natural pathway, but they last much longer in the body than your natural GLP-1 hormone

The 7.5 mg dose step is a good checkpoint to review progress, discuss side effects, and confirm that continued escalation is appropriate

Due to ongoing demand and previous shortages of similar products (such as semaglutide) one would hope that Eli Lilly has anticipated increased demand for Mounjaro in the UK and will have adequate supplies from the outset